Cargando…
Prospective Analysis of the Impact of (68)Ga-DOTATOC Positron Emission Tomography–Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors
OBJECTIVES: A prospective clinical trial evaluated the effect of (68)Ga-DOTATOC positron emission tomography–computerized axial tomography (PET-CT) on change in management of patients with lung, pancreatic, and small bowel neuroendocrine tumors. The primary eligibility criterion was a histologically...
Autores principales: | Ghobrial, Silvia N., Menda, Yusuf, Zamba, Gideon K., Mott, Sarah L., Gaimari-Varner, Kristin, Dick, David, Dillon, Joseph, Howe, James R., Graham, Michael, Sunderland, John, Bellizzi, Andrew, O’Dorisio, Thomas M., O’Dorisio, M. Sue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447173/ https://www.ncbi.nlm.nih.gov/pubmed/32769854 http://dx.doi.org/10.1097/MPA.0000000000001625 |
Ejemplares similares
-
Addition of (131)I-MIBG to PRRT ((90)Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
por: Bushnell, David L., et al.
Publicado: (2021) -
Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors
por: Bushnell, David L, et al.
Publicado: (2014) -
Gastroenteropancreatic neuroendocrine tumors in children and young adults
por: Khanna, Geetika, et al.
Publicado: (2007) -
SUN-LB26 Radioligand Theranostics of Endocrine-Related Cancers; A New, Revolutionary Approach
por: Harris, Alan G, et al.
Publicado: (2020) -
Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP‐NETs: A Review of Key Issues
por: Anthony, Lowell B., et al.
Publicado: (2021)